Timothy M. Kish
Chief Executive Officer presso BeCaid LLC
Profilo
Timothy M.
Kish is the founder of Ren Pharmaceuticals, Inc. He is currently the Chief Executive Officer at BeCaid LLC and also holds a position as President & Chief Financial Officer at RHEI Pharmaceuticals, Inc. Previously, he worked as the Chief Financial Officer & Vice President at Biogen MA, Inc. from 1993 to 2000 and as the Chief Financial Officer at Illumina, Inc. He completed his undergraduate degree at Michigan State University and earned an MBA from the University of Minnesota.
Posizioni attive di Timothy M. Kish
Società | Posizione | Inizio |
---|---|---|
RHEI Pharmaceuticals, Inc.
RHEI Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology RHEI Pharmaceuticals, Inc. acquires licenses, develops and commercializes therapies. The company was founded by Harry H. Penner, John W. Childs, Xin Sylvia He and Glenn A. Hopkins in 2008 and is headquartered in New Haven, CT. | Director of Finance/CFO | - |
BeCaid LLC
BeCaid LLC Miscellaneous Commercial ServicesCommercial Services BeCaid LLC is a scientifically-based cognitive cross training program shown to increase test scores. It designed by neuroscientists from Yale University, the program integrates web-based computer games and physical exercise, and strengthens core cognitive capacities such as attention, memory, and focus. . The company was founded by Bruce E. Wexlerin 2011 and is headquartered in New Haven, CT. | Chief Executive Officer | 01/03/2017 |
Precedenti posizioni note di Timothy M. Kish
Società | Posizione | Fine |
---|---|---|
Biogen MA, Inc.
Biogen MA, Inc. BiotechnologyHealth Technology Biogen MA, Inc. is a biotechnology company principally engaged in discovering and developing drugs for human healthcare through genetic engineering. The company’s research and development activities used to focus on novel products for multiple sclerosis, inflammatory, respiratory, kidney and cardiovascular diseases, developmental biology and gene therapy. The company was founded by Daniel D. Adams in 1976 and is headquartered in Cambridge, MA. | Director of Finance/CFO | 04/01/2000 |
Ren Pharmaceuticals, Inc.
Ren Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Ren Pharmaceuticals was formed in the fall of 2006 with the aim of bringing together talented and experienced people who are passionate about building a cardio-renal/renal- focused drug development company. Ren Pharmaceuticals closed a Series A financing in November 2006 with Sanderling Ventures, Venrock Associates and Amgen Ventures as investors. The company's R&D is currently located in South San Francisco, California. | Founder | - |
ILLUMINA, INC. | Director of Finance/CFO | - |
Formazione di Timothy M. Kish
Michigan State University | Undergraduate Degree |
University of Minnesota | Masters Business Admin |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Società quotate in Borsa | 1 |
---|---|
ILLUMINA, INC. | Health Technology |
Aziende private | 4 |
---|---|
Biogen MA, Inc.
Biogen MA, Inc. BiotechnologyHealth Technology Biogen MA, Inc. is a biotechnology company principally engaged in discovering and developing drugs for human healthcare through genetic engineering. The company’s research and development activities used to focus on novel products for multiple sclerosis, inflammatory, respiratory, kidney and cardiovascular diseases, developmental biology and gene therapy. The company was founded by Daniel D. Adams in 1976 and is headquartered in Cambridge, MA. | Health Technology |
Ren Pharmaceuticals, Inc.
Ren Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Ren Pharmaceuticals was formed in the fall of 2006 with the aim of bringing together talented and experienced people who are passionate about building a cardio-renal/renal- focused drug development company. Ren Pharmaceuticals closed a Series A financing in November 2006 with Sanderling Ventures, Venrock Associates and Amgen Ventures as investors. The company's R&D is currently located in South San Francisco, California. | Health Technology |
BeCaid LLC
BeCaid LLC Miscellaneous Commercial ServicesCommercial Services BeCaid LLC is a scientifically-based cognitive cross training program shown to increase test scores. It designed by neuroscientists from Yale University, the program integrates web-based computer games and physical exercise, and strengthens core cognitive capacities such as attention, memory, and focus. . The company was founded by Bruce E. Wexlerin 2011 and is headquartered in New Haven, CT. | Commercial Services |
RHEI Pharmaceuticals, Inc.
RHEI Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology RHEI Pharmaceuticals, Inc. acquires licenses, develops and commercializes therapies. The company was founded by Harry H. Penner, John W. Childs, Xin Sylvia He and Glenn A. Hopkins in 2008 and is headquartered in New Haven, CT. | Health Technology |
- Borsa valori
- Insiders
- Timothy M. Kish